Advertisement

Topics

Valeant Pharma Continues Asset Sales Instead of 'Riskier' Debt Swaps

13:13 EDT 29 Jun 2017 | The Street

Click to view a price quote on VRX.

Click to research the Drugs industry.

Original Article: Valeant Pharma Continues Asset Sales Instead of 'Riskier' Debt Swaps

NEXT ARTICLE

More From BioPortfolio on "Valeant Pharma Continues Asset Sales Instead of 'Riskier' Debt Swaps"

Advertisement
Quick Search
Advertisement
Advertisement